NLRC5 and neoplasm: Unfortunately, when tumor cells were injected orthotopically or in the peritoneal cavity, no differences were found in tumor development (Figure 5D; Supplementary Figures 4C, D), although there was a trend (p = 0.06) for longer survival in mice with NLRC5+ IP tumors.